Covid UK: AstraZeneca shares fall 1% after regulator says under-30s should not take vaccine
AstraZeneca’s share price has slumped by one per cent after UK health chiefs said Britons under 30 should not take its vaccine. The British-Swedish pharmaceutical firm, based in Cambridge, suffered a blow to its jab this afternoon following mounting evidence linking it to rare blood clots. The company’s shares were trading at 7.110 points on Tuesday … Read more